Abstract. In S. cerevisiae lacking SHR3, amino acid permeases specifically accumulate in membranes of the endoplasmic reticulum (ER) and fail to be transported to the plasma membrane. We examined the requirements of transport of the permeases from the ER to the Golgi in vitro. Addition of soluble COPII components (Sec23/24p, Secl3/31p, and Sarlp) to yeast membrane preparations generated vesicles containing the general amino acid permease, Gaplp, and the histidine permease, Hiplp. Shr3p was required for the packaging of Gaplp and Hiplp but was not itself incorporated into transport vesicles. In contrast, the packaging of the plasma membrane ATPase, Pmalp, and the soluble yeast pheromone precursor, glycosylated pro a factor, was independent of Shr3p. In addition, we show that integral membrane and soluble cargo colocalize in transport vesicles, indicating that different types of cargo are not segregated at an early step in secretion. Our data suggest that specific ancillary proteins in the ER membrane recruit subsets of integral membrane protein cargo into COPII transport vesicles.
I
N S. cerevisiae and other eukaryotes, secreted proteins move intracellularly between membrane-bounded compartments via transport vesicles (Palade, 1975; Pryer et al., 1992) . Soluble and integral membrane proteins destined for subcellular compartments, the plasma membrane, or secretion are imported into the ER where folding, initial glycosyl modifications, and oligomer assembly takes place. Cargo molecules destined for transport are then targeted to the Golgi for further modification and sorting (Rothman, 1994; Schekman, 1992) . The transport of membrane proteins to the plasma membrane (PM) 1 is essential for, among other functions, the maintenance of intracellular pH and the transport of nutrients, such as amino acids into the cell. The yeast genome encodes 17 amino acid permeases of which 11 have defined substrate specificities. These proteins exhibit 30-60% amino acid sequence homology and contain 12 putative transmembrane domains (Andre, 1995; Schmidt et al., 1994) . Components of the Sec machinery are required for permease translocation into the ER (Green et al., 1992) , and for export to the PM (Courchesne and Magasanik, 1983) .
Shr3p, a nonessential integral ER membrane protein, is also required for the localization of amino acid permeases to the plasma membrane of S. cerevisiae in vivo (Ljungdahl et al., 1992) . Immunofluorescence localization showed that amino acid permeases were retained in the ER membrane of shr3 null mutant (Ashr3) cells. Shr3p acts pleitropically on the entire family of amino acid permeases. As a result of diminished levels of amino acid permeases in the PM, Ashr3 cells are resistant to high concentrations of histidine in the growth medium. The transport of soluble cargo, such as carboxypeptidase Y, et factor, and invertase, and membrane proteins, such as the plasma membrane ATPase (Pmalp), appeared unaffected by Ashr3 in vivo. Thus, Shr3p appears to be a specific accessory protein required for the early stage of secretion for a select group of homologous proteins, the amino acid permease family. Vesicle-mediated transport of glycosylated c~ factor precursor (gpetF) from the ER to the Golgi complex has been reconstituted in vitro (Baker et al., 1988) . Three protein fractions comprising two hetero-oligomeric complexes (Sec23/24p and Sec13/31p) and the small ras-like GTPase Sarlp constitute the cytosolic components (COPII) required for vesicle formation (Salama et al., 1993) . Sarlp-GTP and the other proteins form the COPII coat around the vesicle that disassembles upon hydrolysis of GTP by Sarlp, allowing fusion of an uncoated vesicle with Golgi membranes (Barlowe et al., 1994) . Recently, these transport vesicles were also found to carry the GPI (glycosylphosphatidylinositol) anchored cell wall protein Gaslp (Doering and Schekman, 1996) . In addition to cargo proteins, COPII captures the putative vSNARES, Sec22p, Betlp, and Boslp (Lian and Ferro-Novick, 1993; Rexach et al., 1994) . The large peripheral membrane protein Secl6p is involved in the formation of ER-derived vesicles in vivo and is incorporated into the vesicles in vitro (Espenshade et al., 1995) . Another transport pathway composed of the coatomer subunits and Arflp (COPI) promotes vesicle budding originating from ER membranes in vitro (Bednarek et al., 1995) . Cargo proteins in COPI vesicles have not yet been identified, although like COPII vesicles, COPI vesicles carry the same set of vSNAREs.
The view that vesicles indiscriminately transport proteins from the ER to the Golgi (bulk-flow) is no longer tenable. Recycling of escaped proteins from the Golgi complex, though it is important for cell viability, is not the principle means by which protein sorting is achieved. The separation of proteins destined for transport from those designed to remain in the ER is achieved primarily at the moment of transport vesicle budding from the ER. Integral ER membrane proteins such as Sec61p, the translocation pore, and Secl2p, which is closely involved in the budding event, as well as the abundant soluble ER chaperone, Kar2p (BiP), are excluded from transport vesicles . Sorting may be achieved by adaptor proteins such as Emp24p, a transmembrane protein that may be involved in the concentration of a subset of secretory proteins into COPII vesicles (Schimmoller et al., 1995) . Aemp24 cells transport a factor, acid phosphatase, and vacuolar proteins normally, but Gaslp and invertase transport are delayed. Gaslp exit from the ER is further regulated by GPI anchor attachment (Doering and Schekman, 1996) . Emp24p and the GPI anchor may be recognized by subunits of the COPII coat allowing the capture of bound cargo molecules while excluding resident proteins that lack a transport signal (Schekman and Orci, 1996) .
We sought additional examples of protein-selective packaging functions and considered the possiblity that Shr3p may serve to capture the amino acid permeases into transport vesicles. The requirement for Shr3p in the specific packaging of the permeases and other integral membrane and soluble cargo was tested in vitro using membrane preparations derived from SHR3 wild-type and null mutant strains. Our studies show that Shr3p specifically promotes the entry of the permeases into the same COPII vesicles that collect other secretory proteins such as a factor precursor. However, Shr3p appears not to be a cargo adaptor because Shr3p remains localized to the ER membrane.
Materials and Methods

Materials and Media
Unless otherwise noted, reagents were purchased from Sigma Chemical Co. (St. Louis, MO). SUD and SPD are synthetic minimal media (6.7 g/1 yeast nitrogen base without ammonium sulfate and amino acids, Difco Laboratories Inc., Detroit, MI), supplemented with 20 g/l glucose, and 1.0 g/l urea or proline (1.0 g/l), respectively (Ljungdahl et al, 1992) . Where required, SPD was supplemented with either 1 mM or 30 mM L-histidine; appropriate volumes of a filter sterilized 0.5 M L-histidine stock solution were added and the pH was adjusted to 5.5 with 10 N NaOH. The concentration of yeast nitrogen base in SUD and SPD is fourfold higher than the amount normally used in other synthetic media. MVD is a standard synthetic minimal medium (6.7 g/1 yeast nitrogen base without amino acids, Difco) supplemented with 20 g/l glucose. YPD is a complex medium (10 g/1 Bacto yeast extract, 20 g/l Bacto peptone, Difco) supplemented with 20 g/l glucose. Solid media were made by the addition of 15 g/l Bacto agar (Difco). aSS-labeled prepro a factor and crude RSY607 yeast cytosol (~25 mg protein/ml) were prepared as described (Baker et al., 1988) . COPII components were purified as described (Salama et al., 1993; Barlowe et al., 1994) .
Yeast Strain and Plasmid Constructions
Yeast strains are listed in Table I , and the plasmids used are listed in Table II. All yeast strains are isogenic derivatives of AA280. A spontaneous Ade + revertant of AA280 was isolated and crossed to AA288, the resulting diploid was sporulated and tetrads dissected. Two spore-derived colonies with the desired genotypes resulted in PLY120 and PLY127. The ADE2 gene was deleted in PLY127 by cotransformation with BamHI linearized pPL131 and the URA3 based vector YCp50. A red Ade-Ura + transformant was isolated, and the loss of the YCp50 vector was selected for by growth on 5-fluoro orotic acid (5-FOA) resulting in strain PLY132 (Boeke et al., 1984) . PLY170 and PLY171 are derived from meiotic segregants of a diploid strain obtained by mating PLY120 with PLY132. The diploid strain PLDYll6, obtained by mating PLY170 and PLY171, was transformed with a linear EcoRI-SalI fragment of DNA derived from pPL288 containing shr3A5::hisG-URA3-hisG (Alani et al., 1987) . One Ura + transformant was sporulated and tetrads dissected. PLY214 and PLY223 are meiotic segregants of this transformant. Resistance to 30 mM histidine segregated 2:2 and was 100% linked to the URA3 marker. PLY223 was propagated on medium containing 5-FOA to attain the unmarked deletion of shr3A6 resulting in PLY229. PLDYll6 was transformed to Ade+ with a linear EcoRI-KpnI fragment of DNA containing hiplA2::ADE2 derived from plasmid pPL296. PLY198 is a meiotic segregant from one such transformant. PLY198 was subsequently transformed with a linear EcoRI-SalI fragment of DNA derived from pPL288 containing shr3A5::hisG-URA3-hisG to create PLY202. PLY202 was propagated on media containing 5-FOA to attain the unmarked deletion oI shr3A6 resulting in PLY204. MKY951 and MKY952 were made by integrating pRS306(HA-PMA1) into the PMA1 locus of PLY214 and PLY229, respectively. The integration of SalI digested pRS306(HA-PMA1) disrupted pmal and created a full-length version of PMAI containing the HA epitope tag. Chromosomal integration was verified by PCR, and expression of the full-length Pmalp-HA product was monitored by immunoblotting spheroplast lysates from transformed yeast cells.
Plasmids were constructed using standard molecular biological procedures. The unmarked ade2A2 was constructed by digesting pPL130 with BglII and religating to create pPL131. It should be noted that the ade2A2 construct disrupted genes flanking the ADE2 locus: 5' a protein of unknown function, and 3' the RGA1 gene was truncated (Stevenson et al., 1995) . The ade2A2 allele did not noticeably affect the growth rate, mating, or sporulation of yeast strains. Importantly, the ade2d2 allele did not affect any of the shr3 mutant phenotypes, pPL288 was constructed by inserting a blunt end 5-kb BgllI-BamHI hisG-URA3-neo-hisG cassette isolated from pSE1076 (Allen and Elledge, 1994) into HindlII-XhoI digested pPL216, made blunt by treatment with Klenow fragment, pPL261 was made by inserting the XbaI-SalI fragment containing SHR3::FLU2 isolated from pPL230 into XbaI-SalI digested YCp405 (Ma et al., 1987) .
Plasmids used to analyze Hiplp were constructed as follows, pPL248 was created by inserting the 3-kb EcoRI-SalI fragment containing HIP1 from pJT19 into EcoRI-SalI digested pRS316 lacking the BamHI site in the polylinker; pPL273 was constructed by inserting the larger 5.5-kb XhoI HIP1 containing fragment from pJT19 into XhoI digested pRS316 (Sikorski and Hieter, 1989) . pPL253 was constructed by digesting pPL248 with BamHl and BgllI after which the 2.2-kb BglII fragment containing ADE2 from pASZll was inserted (Stotz and Linder, 1990) . pPL282 was made by digesting pPL273 with EcoRI-SalI and inserting the 4-kb EcoRI-SalI fragment containing hiplA::ADE2 from pPL253. The insert of pPL282 was cloned into KpnI-EcoRI digested pBSII SK (+) (Stratagene, La Jolla, CA) resulting in the final deletion construct pPL296.
The construction of pPL321 containing a fully functional Hiplp-myc required multiple steps, pPL302 was made by digesting pPL273 with EcoRI-NotI, the ends were made blunt and religated, pPL304 was constructed by digesting pPL302 with XbaI to remove a 1.5-kb XbaI fragment, following which the ends were filled in and religated. Epitope tagging of HIP1 was performed as described by Kolodziej and Young (1991) using pPL304 as the starting vector and site directed insertion mutagenesis (Kunkel et al., 1987) . pPL308 contains an XbaI site introduced into the HIP1 sequence between amino acid residues 23 and 24. An oligomer enThe Joumal of Cell Biology, Volume 135, 1996coding an XbaI site was annealed to single stranded pPL304 DNA prepared with helper phage M13K07 (Vieira and Messing, 1987) in the dutung-E. coli host, RZ1032 (Kunkel et al., 1987) . After elongation, ligation, and transformation into a dut + ung + host, plasmid DNAs were screened for the presence of the new XbaI site. An XbaI flanked cloning cassette, encoding the c-myc epitope reiterated three times, was inserted into the unique XbaI site of pPL308 resulting in pPL315. To reconstruct sequences 3' of HIP1, we digested pPL315 with AvrlI and the 3 kb AvrlI fragment of pPL302 was inserted. This last cloning step resulted in pPL321 and reintroduced the previously deleted 1.5-kb XbaI fragment.
pRS306 (HA-PMA1) was made by introducing the 2.4-kb HindlIIBamHI fragment of pRS305(HA-PMA1) (Ziman et al., 1996) into the multiple cloning site of pRS306 (Sikorski and Hieter, 1989) lacking the Sail endonuclease site. The Sail site had been removed previously by Sail digestion of pRS306 followed by treatment with the Klenow enzyme and ligase. The resulting plasmid contained a 1.6-kb fragment of PMA1 encoding the epitope tagged NH 2 terminus of Pmalp.
Plasmids encoding epitope-tagged proteins were transformed into yeast using the lithium acetate procedure (Guthrie and Fink, 1991) . Transformants were chosen that expressed the plasmid-encoded proteins as detected by SDS-PAGE immunoblotting of whole cell lysates. The c-myc epitope is recognized by the monoclonal antibody 9El0 (Evan et al., 1985) and the HA epitope is recognized by the monoclonal antibody 12CA5 (Wilson et al., 1984) . The growth phenotype of transformant and parent strains were similar on 1 mM and 30 mM histidine containing SPD media, confirming that the SHR3 locus had not been affected. and PLY204[pPL321] grown at 30°C on appropriately supplemented MVD solid media were used to inoculate stock cultures of supplemented SUD broth. Stock SUD cultures grown at 24°C to 70D~o/ml were used to inoculate YPD broth cultures grown at 24°C overnight to 10D60o/ml. Cells (3 1 total, 10D~0/ml) were harvested, and microsomal membranes prepared as described . Purified microsomal membranes were adjusted to 40 OD280 (~8 mg protein/ml) in B88. The preparation was divided into 50-~1 aliquots, frozen in liquid nitrogen, and stored at -80°C.
Microsome Preparation
Yeast cultures of PLY204[pPL321] [pPL261], PLY198[pPL321],
Microsome-based Cargo Packaging Assay
Two budding reactions were prepared simultaneously, one for ct factor precursor analysis and the other for immunoblotting. Microsomes (0.4 rag) were thawed on ice, 35S-labeled prepro-c~ factor was added to one of the reactions, and both preparations incubated with 1 × ATP regeneration mix (Baker et al., 1988) in a volume of 160 ill for 25 rain at 10°C. Membranes were incubated on ice for 5 min, washed three times with 1 ml B88 (12,000 g), and resuspended in B88. Budding reactions (50 pA) were prepared in duplicate containing N50 p.g microsomes, 0.1 mM GTP, 1 × ATP regeneration mix, and either purified COPII components (1 ~g Secl3/31p, 1 I~g Sec23/24p, and 0.5 p.g Sarlp) or 50 p~g cytosol supplemented with 0.3 Ixg Sarlp. After incubation for 60 min at 20°C, a portion of the total reaction (Total) and the medium-speed supernatant (MSS) (12,000 g, 5 min.) were collected. The percent of 35S-labeled prepro-a factor packaged into vesicles was determined by dividing the amount of protease-protected, Con A-precipitable 35S-gpctF in the MSS by the amount in the Total fraction as described (Rexach and Schekman, 1991) . For analysis of vesicle proteins, the MSS was transfered to siliconized Eppendorf tubes (USP, San Leandro, CA) and sedimented in the TLA100.3 for 15 rain at 90,000 g, at 4°C. Total and high speed pellet fractions were heated in 1X SDS-PAGE sample buffer for 10 min at 55°C and proteins were separated using 12.5% SDS-PAGE and immunoblotted. For the comparison of budding from microsomes prepared from PLY198[pPL321] and PLY204[pPL321], 250 p~l reactions contained 100 p~g membranes incubated with 5 Ixg Secl3/31p, 5 ttg Sec23/24p, and 2.5 I~g Sarlp, or 250 Ixg cytosol supplemented with 1.5/zg Sarlp.
Semi-Intact Yeast Spheroplasts
Yeast cultures of PLY129[pPL269], PLY134[pPL269], MKY951, and MKY952 grown on appropriately supplemented MVD solid media at 30°C were used to inoculate stock cultures of supplemented SUD broth. Stock cultures grown to an ODr00/ml of 2-6 at 24°C were used to inoculate overnight YPD broth cultures that were grown to an ODr0o/ml of 1-2 at 24°C. Cells were harvested, washed twice in MVD, resuspended in supplemented MVD to 5 OD600/ml, and shaken at 30°C for 15 min. The cultures were labeled with 1 mCi/60 OD600/ml 35S-Promix (1,200 Ci/mmol, Amersham) for 3 min at 30°C. Metabolic activity was stopped by the addition of NaN 3 (20 mM final). The cells were incubated on ice for 15 min and washed with cold 20 mM NaN 3. Spheroplast preparation and lysis were performed as described (Doering and Schekman, 1996) .
Immunoprecipitation of cell wall protein (CWP) with polyclonal anti-CWP, prepared by T. Doering and J. Campbell (Univ. of California, Berkeley, CA) as described (Sanz et al., 1987) , and Gaplp-HA from 3SS-labeled semi-intact spheroplast preparations of the isogenic pair PLY129[pPL269] and PLY134[pPL269] showed less overall protein labeling in Ashr3 cells, however the ratio of the two proteins was the same in both strains.
Semi-Intact Spheroplast-based Cargo Packaging Assay
Gently lysed spheroplasts (20--30 OD600 U/tube, ~8 ~g protein/OD600U) were incubated in Stage I translocation reactions as described . Unlabeled washed membranes were exposed to 35S prepro a factor and 1 × ATP regeneration mix at 10°C for 25 min, whereas 3ss metabolically labeled membranes were treated in a mock translocation reaction with only 1 × ATP regeneration mix. For urea treatment, before the budding reactions the membranes were resuspended in 2.5 M urea in B88 (100 ~1), incubated for 10 min on ice, and washed twice with 1 ml B88. Membranes were resuspended in a final volume of 80 ~1 B88.
Budding reactions contained 10 p.1 of membranes (from 1.5-2.5 ODr00 U cells), COPII components (1-2 Ixg Secl3/31p, 1-2 l~g Sec23/24p, and 1 Ixg Sarlp) or 100 p.g crude cytosol supplemented with 1 ~xg Sarlp in a 50-p~l vol with 1 × ATP mix and 0.1 mM GTP. Reactions were incubated at 25°C for 30 min. One-tenth of the sample was removed for analysis (Total), the remaining reaction mixture was centrifuged (12,000 g) at 4°C for 2 min, and 25 i~1 of the supernatant (MSS) was collected. Total and MSS fractions from radiolabeled membranes were analyzed by immunoprecipitation. Fractions from membranes containing translocated 358-a factor precursor were analyzed for protease-protected gpaF as described (Rexach and Schekman, 1991) .
Vesicle Immunoisolation
Vesicle budding reactions using semi-intact spheroplasts performed at 4°C and 25°C were scaled up tenfold and 350 }xl of the resulting MSS was collected and subjected to flotation on a 35%-30%-25%-15% Nycodenz gradient as described previously (Barlowe et al., 1994) . The upper three 400-1~1 fractions were collected. For radiolabeled membranes, 5 I~l of the total reaction, 25 }xl of the MSS, and 50 }xl of each 400 p.l Nycodenz fraction were analyzed by immunoprecipitation. For unlabeled membranes, 5 ~1 of the total reaction and 335 ~1 of each Nycodenz fraction were precipitated in 20% TCA on ice for 5 min, and the precipitated material was collected by centrifugation (12,000 g, 20 min), washed with acetone, and sedimented again (12,000 g, 10 min). TCA precipitated material was analyzed by SDS-PAGE immunoblotting. For membranes containing translocated 35S-prepro-a-factor, 10 I.Ll of the total reaction, 30 ~1 of MSS, and 30 ~L1 of each Nycodenz fraction were analyzed for Con A-precipitable, protease-protected gpctF. To examine the possibility of nonspecific vesicle aggregation, we mixed 200 p.l of MSS containing Gaplp-HA vesicles and 200 i~1 of MSS containing 35S prepro-a-factor vesicles on ice before Nycodenz flotation and immunoisolation.
To immunoisolate vesicles, we discarded the top 100 ~1 of the gradient, and the following 375 Izl was collected and 20 ILl incubated in 5% BSA/ PBS (137 mM NaC1, 2.7 mM KC1, 4.3 mM Na2HPO4.7H20 , 1.4 mM KH2PO4) overnight at 4°C in siliconized Eppendorf tubes (USP, San Leandro, CA) with 10 ILl (0.5 mg/ml) anti-HA epitope monoclonal antibody (12CA5, Boehringer Mannheim, Indianapolis, IN) or affinity-purified anti-Sec22 polyclonal antibody (1 mg/ml) (Bednarek et al., 1995) , in the presence and absence of 1 mg/ml HA peptide (Boehringer Mannheim) or 0A mg/ml Sec22p-GST fusion protein (Bednarek et al., 1995) , respectively. Immunoprecipitated material was washed 4 × with 0.1% BSA/PBS, transferred to a new tube, and washed once with 50 mM NaC1/10 mM Tris-C1, pH 7.5 For nonradiolabeled samples, immunoisolated vesicles were subjected to SDS-PAGE immunoblotting and 125I-Protein A. Immunoreactive proteins were detected using a Phosphorimager (Molecular Dynamics, Sunnyvale, CA). Radiolabeled Gaplp-HA in a portion of the total membrane material, the MSS, and the immunoisolated material were immunoprecipitated under denaturing conditions with the HA antibody. lmmunoprecipitates were washed, subjected to SDS-PAGE, and analyzed HindlII-BamHI fragment containing HAThis work PMA1 in pRS306(ASalI) using a Phosphorimager. To quantify colocalization of 35S-gpctF, we treated immunoisolated material with protease, followed by solubilization and Con A precipitation of the protease-protected material. This quantity was compared with the amount of protease-protected, Con A-precipitable 35S-gpctF in the native immunoprecipitation supernatant.
Immunoprecipitation and Western Blotting
Immunoprecipitation reactions were prepared by heating the sample in B88 with an equal volume of denaturing buffer (1% SDS, 50 mM Tris, pH 7.4, 1 mM EDTA, and 1 mM PMSF) for 10 min at 50°C. The sample was adjusted to 1 ml with IP buffer (150 mM NaC1, 1% Triton X-100, 0.05% SDS, 15 mM riffs CI, pH 7.5), 10 ixl (5 I~g) HA antibody, and 50 ~1 30% protein G-Sepharose in PBS, and the reactions were incubated for 2 h, rotating at 25°C. Immunoprecipitates were washed as described (Baker et al., 1988) . Immunoprecipitated material was heated in reducing, denaturing sample buffer at 55°C for 10 rain, resolved by SDS-PAGE, and analyzed using a Phosphorimager.
For immunoblotting, proteins were heated in sample buffer at 55°C for 10 min, resolved by SDS-PAGE, and transferred to 0.2 ~m nitrocellulose (Millipore, Bedford, MA) or PVDF (Millipore) at 250 mA for 1.5 h. Strips of the blot were incubated at 25°C for 1 h with 3% nonfat dry milk in TBST (50 mM Tris-HC1, pH 7.4, 150 mM NaC1, 0.1% Tween 20), and incubated for 2 h with affinity-purified anti-Sec61p polyclonal antibodies (1: 5,000 in TBST) (Stifling et al., 1992) , affinity-purified anti-Sec22p polyclonal antibodies (1:1,000), anti-myc epitope monoclonal antibodies (9El0, 1:3,000) (Evan et al., 1985) , anti-HA antibodies (1:3,000), or purified lgG (~1 mg/ml) from anti-Betlp polyclonal antibodies (1:500) . Immunoreactive proteins were detected by chemiluminescence (ECL, Amersham) and autoradiography, or by 125I-Protein A (ICN, Biomedicals, Inc., Costa Mesa, CA) and Phosphorimaging.
Results
Amino Acid Permeases Hipl and Gapl, but Not the Permease Chaperone Shr3p, Are Packaged into COPII Transport Vesicles
The yeast pheromone precursor, glycosylated pro-~ factor (gpaF), is a marker for soluble protein cargo in secretory vesicles that bud from ER membranes in vitro (Baker et al., 1988; Rexach and Schekman, 1991) . In this budding assay, radiolabeled prepro-tx factor is posttranslationally translocated into ER membranes where its signal sequence is cleaved and it becomes core glycosylated. When such membranes are incubated with purified COPII components or cytosol, gpetF is packaged into vesicles that can be separated from larger membranes by a medium-speed centrifugation step. The efficiency of gpaF packaging is measured as the fraction of total gpaF found enclosed within vesicles in the medium-speed supernatant fraction (MSS).
To investigate the packaging of amino acid permeases in vitro, we introduced single copy plasmids encoding an epitope-tagged permease into yeast strains containing a disruption of the wild-type permease gene (Tables I and  II) . Plasmids pPL269 and pPL321 encoding the tagged permeases Gaplp-HA and Hiplp-myc were transformed into the respective permease deletion strains PLY129 and PLY198. Epitope-tagged Gaplp-HA and Hiplp-myc are expressed and are localized to the PM where they are fully functional (Ljungdahl et al., 1992 ; and data not shown).
Strain PLY204 which has deletions in the HIP1 and SHR3 loci was transformed with pPL261 encoding HA-tagged Shr3p (Shr3p-HA), and pPL321, encoding Hiplp-myc.
Strains deleted in SHR3 and transformed with the epitope-tagged version of SHR3 behaved as wild-type strains with regard to growth on a low concentration of histidine and sensitivity to a high concentration of histidine (Ljungdahl et al., 1992 ; and data not shown).
The strains containing epitope-tagged proteins were analyzed using a modified budding assay (see Materials and Methods) to investigate the incorporation of integral membrane proteins into transport vesicles in vitro. Microsomal membranes prepared from Ashr3 cells expressing Shr3p-HA and Hiplp-myc were incubated with either COPII proteins or whole cytosol to generate vesicles. The MSS was then subjected to high-speed centrifugation (90,000 g) to sediment the vesicles. Hiplp was detected in vesicle pellets from incubations containing nucleotide and either cytosol or the purified COPII components (Fig. 1) . The cargo molecule gpe~F and the putative v-SNARE Sec22p were also found in these vesicles (Fig. 1) . Similar results were obtained using purified yeast nuclei, a highly enriched preparation of ER membrane (data not shown). In contrast, Shr3p and the ER resident protein Sec61p were not detected in the vesicle fractions (Fig. 1) . These data indicate that Hiplp enters COPII vesicles whereas Shr3p is not transported out of the ER in vitro.
We wanted to examine the vesicle packaging of permeases quantitatively, but contamination of microsomal membranes with plasma membrane fragments prevented accurate measurement of the low level of nascent permeases in transit from the ER. For this reason, we used spheroplast membranes prepared from cells that had been pulse-radiolabeled for 3 min with [35S]methionine. This short pulse essentially labels only ER transport intermediates. Such pulses have previously been used to biochemically follow the ER forms of Pmalp, another integral membrane protein destined for the PM (Chang and Slay- 
Microsomes made from PLY204[pPL261]
[pPL321] were used in duplicate vesicle budding reactions which contained: GTP, nucleotides alone; COPI1, nucleotides and purified COPII components; Cyt, nucleotides and cytosoi supplemented with Sarlp; H, COPII components without membranes; and C, Cytosol without membranes. Medium speed supernatant (MSS) fractions collected by high speed centrifugation and one-third of the total reaction mixture (Tom/) were resolved by SDS-PAGE, and immunobiotted using anti-myc, anti-Sec61p, anti-Sec22p, and anti-HA antibodies, followed by ECL detection and autoradiography. In parallel duplicate reactions where 35S-prepro-et-factor was translocated posttranslationally into the microsomes, protease-protected 35S-gpaF in the MSS was measured and the average of the values are indicated at the bottom of the figure. man, 1991). Because we were unable to immunoprecipitate Hiplp from radiolabeled membranes, the G a p l p permease was examined in this modified assay.
Perforated spheroplasts were prepared from radiolabeled gaplA cells expressing G a p l p -H A and used in budding reactions. G a p l p -H A was immunoprecipitated from the MSS in reactions that contained GTP, ATP, and either whole cytosol or all three purified COPII proteins ( Fig.  2 A) ; omission of any one COPII protein reduced the level of G a p l p -H A packaging. Immunoprecipitated G a p l p -H A was packaged with 35-45% efficiency into COPII vesicles (Fig. 2 B) , similar to that for et factor precursor (Fig. 2 C) . The dependence on each of the COPII components for packaging was also found for Hiplp using the microsome assay described above (data not shown). These results demonstrate that the membrane permeases, like soluble cargo, require each of the COPII components and nucleotide for packaging into transport vesicles.
Shr3p Is Required for In Vitro Packaging of Permeases into Vesicles
We next examined the effect of an shr3 null mutation on the ability of the permeases to exit the ER in vitro. Hiplp packaging from SHR3 and dshr3 membranes was investigated using microsomal membranes and an immunoblot assay. Hiplp-myc was not detected above background levels in the MSS in reactions using ~shr3 membranes with COPII or cytosol (Fig. 3 A) . A quantitative difference in permease packaging from SHR3 and Ashr3 membranes was determined using 3-min pulse-labeled membranes prepared from isogenic cells expressing Gaplp-HA. z~shr3
membranes did not release immunoprecipitable G a p l p into the MSS in reactions containing either cytosol or COPII (Fig. 3 B) . By quantitative phosphorimager analysis, we found that G a p l p packaging into vesicles from dshr3 membranes was reduced at least 90% compared to SHR3 membranes (Fig. 3 C) . These data demonstrate that the amino acid permeases require the ER resident membrane protein, Shr3p, to be packaged into transport vesicles in vitro.
a Factor and Praalp Packaging into Vesicles Is Independent of Shr3p
We investigated whether the effect of the Shr3p deletion was specific to the amino acid permeases, et factor secretion and transport of the major plasma membrane protontranslocating ATPase (Pmalp) are not affected in vivo by
Ashr3 (Ljuugdahl et al., 1992) . We looked for the presence of these cargo in vesicles produced from 2,shr3 membranes in vitro. 35S-gpetF packaging was quantitfied from "mocklabeled" permeabilized spheroplasts that were prepared similarly to the metabolically labeled membrane preparations described above. The efficiency of gpaF precursor packaging was similar using SHR3 and ~shr3 membranes (Fig. 4 A) . Although the experiment depicted in Fig. 4 A indicates a partial reduction in gpetF packaging using COPII components with z~shr3 membranes, this pattern was not seen in assays involving other isogenic SHR3/ z~shr3 pairs (data not shown). Doubling the level of COPII proteins increased the efficiency of gpaF packaging from dshr3 membranes whereas no such stimulation of Gaplp
The Journal of Cell Biology, Volume 135, 1996 . Duplicate vesicle budding reactions contained: no nucl, COPII components; COPII, nucleotides and COPII components; Cyt, nucleotides and cytosol supplemented with Sarlp; and 4°C, nucleotides and cytosol supplemented with Sarlp incubated at 4°C. Radiolabeted Gaplp-HA was immunoprecipitated from one-fifth of the total reaction mixture and the MSS from each reaction using anti-HA mAb. Immunoprecipitated material was resolved by SDS-PAGE and analyzed using a phosphorimager. (C) Quantitation of phosphorimager signals correspond to the percent of GapIp-HA in the MSS of each reaction compared with the total reaction. Solid (SHR3) and hatched bars (zlshr3) represent the average of three data sets.
packaging from zlshr3 membranes was observed (data not shown). These results show that in vitro, as in vivo, vesicle transport of soluble cargo is independent of Ashr3. Next, we examined the packaging of Pmalp. The plasma membrane ATPase Pmalp is abundant, comprising at least 5-10% of the PM proteins (Serrano et al., 1986; Serrano, 1989) , and consists of 8-10 transmembrane domains with its ATPase activity localized to a large cytoplasmic domain positioned after the first four transmembrane domains. Pmalp export is mediated by the Sec pathway in vivo (Chang and Slayman, 1991; Brada and Schekman, 1988; Holcomb et al., 1988; Walworth and Novick, 1987) . Epitope-tagged Pmalp was introduced into the chromosome at the PMA1 locus by integrative recombination in both SHR3 and Ashr3 cells. Permeabilized spheroplasts were prepared from 35S pulse-labeled (3 min) cells of each strain and used in the in vitro vesicle budding assay to assess Pmalp packaging. P m a l p -H A was immunoprecipitated from the MSS in reactions using whole cytosol and either SHR3 or zlshr3 membranes (Fig. 4 B , quantitation in Fig. 4 C) . Interestingly, COPII consistently was only half as efficient as cytosol in the packaging of Pmalp into vesicles (data not shown). These results demonstrate that Pmalp is a detectable vesicle cargo protein in vitro, and, like a factor, is independent of Shr3p.
Factor Precursor and Gaplp-HA Reside in the Same Vesicle
To further characterize the population of membranes that contain the amino acid permeases, we fractionated the MSS on a Nycodenz step gradient such that small vesicles float to the top whereas larger membrane fragments remain at the bottom (Barlowe et al., 1994) . Gaplp was detected in the same upper step of the gradient as gpaF and Sec22p, whereas the ER membrane marker, Sec61p, did not float (Fig. 5, A and B) . These data suggest that G a p l p resides in vesicles that have the same general properties as those that contain gp~xF.
Sorting of cargo molecules is thought to occur at late stages in the secretory pathway (Harsay and Bretscher, 1995; Rothman, 1994) . We were interested in determining whether integral membrane and soluble cargo proteins were sorted into distinct COPII vesicles. Because the epitope tag on G a p l p is predicted to reside on the cytosolic side of the membrane, and thus be accessible to antibodies, we had the opportunity to immunoprecipitate Gaplp-HA-containing vesicles to evaluate coincident localization of gptxF. Vesicle populations were immunoisolated after flotation on a Nycodenz step gradient. Nycodenz removes most of the COPII coat (Barlowe et al., 1994) allowing better epitope recognition by the antibody. Native immunoprecipitation using a saturating amount of anti-HA antibody recovered 65 % of the G a p l p -H A found in the Nycodenz-floated material; recovery was completely inhibited by the H A peptide (1 mg/ml). Anti-HA antibody coprecipitated 71% of the gpetF and detectable amounts of the vSNAREs, Betlp and Sec22p, present in the Nycodenz-floated vesicles (Fig. 5 C) . Similar results were obtained using cytosol or purified COPII components to generate the vesicles. In addition, we prepared a mixture of vesicles, half carrying Gaplp-HA and not containing 35S-gpaF, and half not carrying G a p l p -H A but containing 35S-gpo~F, which were floated on a Nycodenz gradient. The presence of Gapl-HA-carrying vesicles did not cause the coisolation of 35S-gpetF recovered with anti-HA antibody (8%, background level: 3-7%). These data indicate that only vesicles carrying the epitope tag were immunoprecipitated and thus nonspecific agglutination of vesicles did not occur during the procedure. Our results support the hypothesis that soluble and membrane cargo reside in the same ERderived transport vesicle and suggest that protein sorting occurs at a later step in secretion.
Discussion
We were interested in determining the requirements for in vitro packaging of the integral membrane amino acid permease proteins into transport vesicles. By modifying methods described previously for the packaging of a factor precursor in vitro, we were able to follow newly synthesized integral membrane proteins as cargo molecules in ER-derived transport vesicles. A similar approach was used to identify Gaslp, a GPI-anchored protein, as vesicle cargo (Doering and Schekman, 1996) . We found that Hiplp and G a p l p are packaged into vesicles driven by Sec proteins found in a cytosol fraction, and that the same degree of packaging of these cargo could be achieved using purified COPII components, Sec13/31p, Sec23/24p, and Sarlp (Figs. 1-3) .
Pmalp, another integral plasma membrane protein, was observed as cargo in vesicles generated from ER by crude cytosol (Fig. 4, B and C) . Whereas the permeases were exported as effectively by the COPII components as by whole yeast cytosol, the amount of Pmalp packaged into vesicles by the purified COPII components was only about half the amount observed using cytosol (data not shown). Thus, additional soluble factors may be required for the in vitro packaging of Pmalp into vesicles. Accumulation of plasma membrane ATPases in proliferated ER upon expression of dominant lethal pmal mutants or plant PM ATPases in yeast suggests that a limiting ER chaperonetype protein may be responsible for the transport of Pmalp to the PM (Harris et al., 1994; Villalba et al., 1992; de Kerchove d'Exaerde et al., 1995) . AST1 encodes a membraneassociated cytosolic protein suppresses the growth defect of mutant prnal cells by localizing mutant Pmalp to the PM (Chang and Fink, 1995) . Immunofluorescence data show that Astlp is present in punctate cytoplasmic locations and at the cell perimeter, but is excluded from the nucleus and the vacuole. These data suggest a possible role for cytosolic Astlp in Pmalp vesicle transport. [pPL269] semi-intact spheroplasts, the amount of trypsin resistant 35S-gpaF present in the MSS compared with the total reaction mixture was determined for each of the assay conditions described in Fig. 3 B. Solid (SHR3) and hatched bars (Ashr3) represent the average of three data sets. (B) 35S-pulse-labeled permeabilized spheroplasts were prepared from SHR3 and Ashr3 isogenic strains MKY951 and MKY952. Duplicate vesicle budding reactions contained: Cyt, nucleotides and cytosol supplemented with Sarlp; and 4°C, nucleotides and cytosol supplemented with Sarlp incubated at 4°C. Radiolabeled Pmalp-HA was immunoprecipitated from onefifth of the Total reaction mixture and the MSS from each reaction using anti-HA mAb. Immunoprecipitated material was resolved by SDS-PAGE and analyzed using a phosphorimager. (C) In duplicate parallel reactions using MKY951 and MKY952 permeabilized spheroplasts, the amount of trypsin resistant 35S-gpaF present in the MSS compared with the total reaction mixture was determined for each of the assay conditions described in B. Solid (SHR3) and hatched bars (dshr3) represent the average of three data sets. Figure 5 . Sec22p, Betlp, and gpetF copurify with vesicles containing Gaplp-HA. (A) MSS generated in vesicle budding reactions performed at 4°C or 25°C were subjected to Nycodenz density gradient flotation. Radiolabeled Gaplp-HA was immunoprecipitated using anti-HA mAb: T, one-fifth of the total budding reaction mixture; M, the MSS from the budding reaction; and 1, 2, and 3, 400-~1 fractions collected starting from the top of the Nycodenz gradient. Immunoprecipitated material was resolved by SDS-PAGE and analyzed using a phosphorimager. The amount of 35S-gpctF present in the Nycodenz fractions is expressed as a percent of the amount loaded onto the gradient in a typical parallel experiment (average of duplicates). (B) T membranes and Nycodenz floated fractions 1, 2, and 3 described in A were analyzed by SDS-PAGE immunoblotting using anti-Sec61p and antiSec22p antibodies, and visualized by ECL autoradiography. (C) Vesicles purified by Nycodenz gradient flotation were immunoprecipitated with anti-HA mAb in the presence (+) or absence ( -) of 1 mg/ml HA peptide. The Nycodenz floated material (Total) and the immunoprecipitated material (anti-HA) were resolved by SDS-PAGE, immunoblotted using anti-Sec22p and anti-Betlp antibodies, and the proteins detected using 125I-Protein A and Phosphorimager analysis. The amount of radiolabeled Gaplp-HA in immunoisolated vesicles is expressed as a percent of the amount in the Nycodenz floated fraction. 35S-gpetF in immunoisolated vesicles is expressed as a percent of the material present in each native immunoprecipitation reaction.
Nycodenz flotation and immunoprecipitation of the vesicles showed that Gapl resides in the same vesicles as et factor precursor and the putative v-SNAREs, Betlp, and Sec22p (Fig. 5) . It is not yet clear whether Pmalp resides in the same vesicles as other membrane and soluble cargo. These results show that permeases are transported out of the ER in COPII vesicles and implies that the separation of cargo with different destinations occurs at a step beyond the ER in the secretory pathway.
Shr3p is clearly required for the exit of the permeases Hiplp and G a p l p from the ER in vitro (Fig. 3) . The defect in permease packaging by dshr3 membranes is not overcome by a soluble cytosolic factor. Although immunofluorescence data demonstrated that the integral membrane protein Shr3p exists primarily in the ER (Ljungdahl et al., 1992) , we considered the possibility that Shr3p entered secretory vesicles and then was recycled back to the ER. Unlike the vSNARE Sec22p Yeung et al., 1995) , or the sorting accessory protein, Emp24p (Schimmoller et al., 1995) , which cycle between the ER and the c/s-Golgi, Shr3p is not packaged into cargo vesicles in vitro (Fig. 1) . This behavior suggests that Shr3p is a true ER resident protein, interacting only transiently with the permeases before they enter cargo vesicles.
The packaging of et factor precursor or Pmalp is independent of Shr3p (Fig. 4) , thus Shr3p does not appear to be a universal link between the ER membrane and the budding machinery. The result that ~Ishr3 membranes are not generally defective in the export of PM proteins demonstrates that dshr3 membranes retain a normal sorting and budding apparatus.
Shr3p plays a specific, critical role in the secretion of permeases from the ER in vivo and in vitro. The presence of ER chaperones to regulate the secretion of a specific subset of proteins appears to be a wide-spread phenomenon in yeast and mammalian cells and the chaperone's function depends on the particular secreted protein. In yeast, the soluble ER chaperone BiP functions in translocation and folding of soluble proteins (Gething and Sambrook, 1992) . Calnexin plays a role in quality control of glycosylation before proteins are allowed to exit the ER (Hammond and Helenius, 1995) . Previous studies have identified several membrane protein chaperones required for proper intracellular localization of secretory proteins, stabilizing intermediates of a growing oligomeric complex, and preventing the activity of proteins during their transit through the secretory pathway. Anplp is an ER membrane protein involved in the correct localization of early Golgi glycosylation machinery (Chapman and Munro, 1994) . Vmal2p, a 25-kD integral vacuolar membrane protein, is required for vacuolar ATPase (vATPase) assembly and influences the stability of the 100-kD and 17-kD integral membrane subunits of vATPase (Hirata et al., 1993) . The authors speculate that Vmal2p may be present along earlier steps in the secretory route to prevent the ATPase from transporting H ÷ into the ER and vesicular compartments. Vma21p, another integral membrane protein responsible for vATPase assembly, is thought to cycle between the ER and the Golgi and also stabilizes the 100-kD integral membrane component of the vATPase (Hill and Stevens, 1994) . In human kidney cells, the 39-kD receptorassociated protein (RAP) binds the low density lipopro-tein receptor-related protein (LRP) in the ER to modulate the aggregation and ligand binding activity of LRP along the secretory pathway (Bu et al., 1995) . In Drosophila, the interaction between the cyclophilin NinaA and the opsins Rhl and Rh2 closely resembles the relationship between Shr3p and the permeases in yeast. In the absence of NinaA, Rhl and Rh2, but not Rh3 and Rh4, accumulate in the ER, however, unlike Shr3p, NinaA is also found in distal compartments of the secretory pathway (Baker et al., 1994; Colley et al., 1991) .
It is possible that Shr3p acts in a typical "chaperone" fashion by influencing the conformation, assembly, or activity of the associated permeases. It is unlikely that Shr3p influences translocation of the permeases, because the localization of transmembrane domains appears unperturbed in reporter-fusion constructs made with the permeases in Ashr3 cells (Gilstring, F., and P.O. Ljungdahl, unpublished data). If permeases oligomerize, Shr3p could facilitate subunit assembly in the ER or prevent premature oligomerization. Alternatively, Shr3p may act at the level of quality control by detecting a particular mature conformation achieved by the permease when it is ready to leave the ER.
A strong possibility exists that Shr3p and other transport chaperones communicate with the budding components of the Sec machinery. Shr3p could act either by contacting the permeases and the COPII components directly or by indirectly mediating permease entry into transport vesicles. A genetic approach is currently underway to investigate the interaction of Shr3p and the COPII budding components. Acting as an intermediary between the permeases and COPII, Shr3p could direct the budding components to an area of the membranes rich in permease cargo proteins, thereby participating in permease packaging without leaving the ER. Alternatively, Shr3p could mediate the interaction of the permeases with a cargo adaptor protein such as Emp24p. Shr3p could also play an active role in regulating permease secretion in response to stressful growth conditions. A cytosolic signaling molecule could modulate the interaction between Shr3p and the permeases, and thereby change the number of permeases that are directed into a budded vesicle. The analytical in vitro methods described in this paper can be used to explore many of these possibilities.
